Cell MedX Corp.Cell MedX Corp.Cell MedX Corp.

Cell MedX Corp.

No trades
See on Supercharts
Market capitalization
‪9.21 M‬USD
−0.0029USD
‪−495.04 K‬USD
‪2.76 K‬USD
‪58.44 M‬
Beta (1Y)
‪15.39 K‬

About Cell MedX Corp.

CEO
David M. Jeffs
Headquarters
West Vancouver
Founded
2010
FIGI
BBG00475SGM2
Cell MedX Corp. is a biotech company, which engages in the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include Microcurrent Therapy and eBalance Systems. The company was founded on March 19, 2010, and is headquartered in Carson City, NV.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CMXC is 0.0310 USD — it has increased by 3.33% in the past 24 hours. Watch Cell MedX Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cell MedX Corp. stocks are traded under the ticker CMXC.
CMXC stock is 3.23% volatile and has beta coefficient of ‪15.39 K‬. Track Cell MedX Corp. stock price on the chart and check out the list of the most volatile stocks — is Cell MedX Corp. there?
Yes, you can track Cell MedX Corp. financials in yearly and quarterly reports right on TradingView.
CMXC stock has risen by 40.91% compared to the previous week, the month change is a 106.67% rise, over the last year Cell MedX Corp. has showed a ‪3.10 M‬% increase.
CMXC net income for the last quarter is ‪119.97 K‬ USD, while the quarter before that showed ‪−60.55 K‬ USD of net income which accounts for 298.15% change. Track more Cell MedX Corp. financial stats to get the full picture.
Today Cell MedX Corp. has the market capitalization of ‪11.82 M‬, it has increased by 36.36% over the last week.
No, CMXC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CMXC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cell MedX Corp. stock right from TradingView charts — choose your broker and connect to your account.
CMXC reached its all-time high on Mar 24, 2014 with the price of 1.8000 USD, and its all-time low was 0.000001 USD and was reached on Mar 24, 2023. View more price dynamics on CMXC chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cell MedX Corp. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cell MedX Corp. stock shows the sell signal. See more of Cell MedX Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cell MedX Corp. EBITDA is ‪−216.16 K‬ USD, and current EBITDA margin is ‪−16.21 K‬%. See more stats in Cell MedX Corp. financial statements.